Surrozen (SRZN) Assets (2020 - 2026)

Surrozen (SRZN) posted quarterly Assets of $120.7 million for Q1 2026, up 5.12% year-over-year from $114.8 million in Q1 2025, and up 22.27% quarter-over-quarter from $98.7 million in Q4 2025.

Surrozen (SRZN) Assets (2020 - 2026) Analysis & Trends

Surrozen's Assets history runs 7 years deep, the most recent figure standing at $120.7 million for Q1 2026.

  • In Q1 2026, Assets rose 5.12% year-over-year to $120.7 million; the TTM figure through Mar 2026 stood at $120.7 million (up 5.12% YoY), while the FY2025 annual figure was $98.7 million, up 103.7% from the prior year.
  • Assets for Q1 2026 stood at $120.7 million, up from $98.7 million in the prior quarter.
  • The five-year high for Assets was $120.7 million in Q1 2026, with the low at $36.7 million in Q1 2024.
  • The 5-year median for Assets is $89.4 million (2022), against an average of $79.4 million.
  • The sharpest annual moves came in 2024 and 2025: Assets slumped 50.52% in 2024, then surged 212.75% in 2025.
  • Surrozen's Assets stood at $89.4 million in 2022, then tumbled by 48.48% to $46.1 million in 2023, then climbed by 5.18% to $48.5 million in 2024, then jumped by 103.7% to $98.7 million in 2025, then increased by 22.27% to $120.7 million in 2026.
  • Business Quant data shows SRZN's Assets at $120.7 million in Q1 2026, $98.7 million in Q4 2025, and $94.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 27.42 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 41.73 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 10.03 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 4.32 Bn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 9.18 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 15.59 Mn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 19.82 Bn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 5.56 Bn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 2.10 Bn
10 Surrozen 281.63 Mn 281.63 Mn - 115.61 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 115.61 Mn
Mar 31, 2026 120.71 Mn
Dec 31, 2025 98.73 Mn
Sep 30, 2025 94.05 Mn
Jun 30, 2025 102.70 Mn
Mar 31, 2025 114.83 Mn
Dec 31, 2024 48.47 Mn
Sep 30, 2024 48.00 Mn
Jun 30, 2024 45.07 Mn
Mar 31, 2024 36.72 Mn
Dec 31, 2023 46.08 Mn
Sep 30, 2023 53.97 Mn
Jun 30, 2023 64.00 Mn
Mar 31, 2023 74.20 Mn
Dec 31, 2022 89.44 Mn
Sep 30, 2022 91.43 Mn
Jun 30, 2022 104.13 Mn
Mar 31, 2022 117.66 Mn
Dec 31, 2021 137.17 Mn
Sep 30, 2021 150.64 Mn